Key Decisions Approved

1. Financial Results Approval

The Board of Directors approved:

  • Un-audited Standalone Financial Results along with Limited Review Report for the quarter and half year ended September 30, 2026
  • Un-audited Consolidated Financial Results along with Limited Review Report for the quarter and half year ended September 30, 2026

2. Merger Approval

The Board approved the merger of Imeds Global Private Limited (wholly-owned subsidiary) into Avantel Limited (Transferee Company). The merger is pursuant to Sections 230 to 232 and other applicable provisions of the Companies Act, 2013, and is subject to requisite statutory and regulatory approvals.

3. Director Appointment

The Board appointed Mr. Nimmagadda Sreenivasa Rao (DIN: 09658001) as an Additional Director, designated as Director (Technical), for a term of three consecutive years from October 26, 2026 to October 25, 2029. The appointment is liable to retire by rotation and subject to approval of members through Postal Ballot.

4. Postal Ballot Notice

The Board approved the Notice of Postal Ballot for seeking member approval for the appointment of Mr. Nimmagadda Sreenivasa Rao as Director (Technical).

Meeting Details

The Board meeting commenced at 11:00 AM IST and concluded at 2:40 PM IST on October 26, 2026.

Financial Performance Highlights

Standalone Results (in ₹ Lakhs)

Quarter Ended September 30, 2026:

  • Revenue from operations: ₹7,382.45
  • Total income: ₹7,413.54
  • Profit before tax: ₹1,116.91
  • Current tax: ₹281.98
  • Deferred tax: ₹43.70
  • Net profit: ₹834.93
  • EPS (Basic & Diluted): ₹0.31

Half Year Ended September 30, 2026:

  • Revenue from operations: ₹14,394.79
  • Total income: ₹14,437.42
  • Profit before tax: ₹2,209.10
  • Current tax: ₹612.41
  • Net profit: ₹1,596.69
  • EPS (Basic & Diluted): ₹0.60

Consolidated Results (in ₹ Lakhs)

Quarter Ended September 30, 2026:

  • Revenue from operations: ₹7,442.07
  • Total income: ₹7,472.14
  • Profit before tax: ₹962.72
  • Current tax: ₹281.98
  • Net profit: ₹680.74
  • EPS (Basic & Diluted): ₹0.26

Half Year Ended September 30, 2026:

  • Revenue from operations: ₹14,484.23
  • Total income: ₹14,525.26
  • Profit before tax: ₹1,831.35
  • Current tax: ₹612.41
  • Net profit: ₹1,218.94
  • EPS (Basic & Diluted): ₹0.46

Segment-wise Performance (Consolidated)

The company operates in two segments:

Communications and Signal Processing Products:

Quarter Ended September 30, 2026:

  • Revenue: ₹7,411.67 lakhs
  • Segment result: ₹1,116.91 lakhs profit

Half Year Ended September 30, 2026:

  • Revenue: ₹14,434.44 lakhs
  • Segment result: ₹2,209.10 lakhs profit

Health Care:

Quarter Ended September 30, 2026:

  • Revenue: ₹60.47 lakhs
  • Segment result: ₹(154.19) lakhs loss

Half Year Ended September 30, 2026:

  • Revenue: ₹90.82 lakhs
  • Segment result: ₹(377.75) lakhs loss

Key Financial Position Highlights (Standalone)

As at September 30, 2026:

  • Total assets: ₹57,641.06 lakhs
  • Property, plant and equipment: ₹20,732.25 lakhs
  • Inventories: ₹14,540.96 lakhs
  • Trade receivables: ₹9,044.70 lakhs
  • Equity share capital: ₹5,315.58 lakhs
  • Borrowings: ₹10,698.41 lakhs (₹3,230.54 non-current + ₹7,467.87 current)

Cash Flow Highlights (Standalone)

Half Year Ended September 30, 2026:

  • Net cash from operating activities: ₹128.00 lakhs
  • Net cash used in investing activities: ₹(6,848.80) lakhs
  • Net cash from financing activities: ₹6,331.10 lakhs
  • Net decrease in cash: ₹(389.70) lakhs

Important Notes to Financial Results

Standalone Notes:

1. Financial results prepared in accordance with Indian Accounting Standards (Ind AS)

2. No provision for loss allowance on receivables as principal customer is government-controlled organization

3. Employee benefit expenses include ₹114.48 lakhs (quarter) and ₹250.07 lakhs (half year) for ESOP 2023

4. Company operates in a single segment

5. Results reviewed by Audit Committee and taken on record by Board on October 26, 2026

Consolidated Notes:

1. Includes financial results of subsidiary iMeds Global Private Limited, India

2. Subsidiary results not reviewed by their auditors: Revenue ₹60.47 lakhs (quarter), ₹90.82 lakhs (half year); Net loss ₹(154.19) lakhs (quarter), ₹(377.75) lakhs (half year)

3. Management considers subsidiary results not material to the Group

4. Employee benefit expenses include ₹114.48 lakhs (quarter) and ₹250.07 lakhs (half year) for ESOP 2023

Additional Information

The financial results are available on BSE Limited, National Stock Exchange of India Limited websites, and the company's website.